Renalytix plc SEC filings RENXF
Renalytix plc has 233 filings in SEC EDGAR's recent list, going back to May 15, 2020. Its latest annual report, Form 10-K, was filed on Sep 30, 2024 for the period ended Jun 30, 2024. The latest quarterly report (Form 10-Q) was filed on Nov 19, 2024, covering the quarter ended Sep 30, 2024. The most recent current report (Form 8-K) was filed on Jan 16, 2025 (regulation fd disclosure). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jul 30, 2025 | — |
| EFFECT | Filing | Jul 30, 2025 | — |
| EFFECT | Filing | Jul 30, 2025 | — |
| EFFECT | Filing | Jul 30, 2025 | — |
| EFFECT | Filing | Jul 30, 2025 | — |
| 15-12G | Deregistration | Jul 30, 2025 | — |
| NT 10-Q | Notification of late filing | Nov 14, 2024 | Sep 30, 2024 |
| 25 | Filing | Oct 7, 2024 | — |
| EFFECT | Filing | Jun 28, 2024 | — |
| CORRESP | Letter to the SEC | Jun 26, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 11, 2024 | — |
| EFFECT | Filing | Apr 29, 2024 | — |
| CORRESP | Letter to the SEC | Apr 25, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 25, 2024 | — |
| DEFR14A | Filing | Nov 13, 2023 | — |
| EFFECT | Filing | Oct 6, 2023 | — |
| EFFECT | Filing | Oct 6, 2023 | — |
| EFFECT | Filing | Oct 6, 2023 | — |
| CORRESP | Letter to the SEC | Oct 5, 2023 | — |
| RW WD | Filing | Oct 3, 2023 | — |
| CORRESP | Letter to the SEC | Oct 2, 2023 | — |
| RW | Filing | Oct 2, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 2, 2023 | — |
| CORRESP | Letter to the SEC | Sep 29, 2023 | — |
| EFFECT | Filing | May 10, 2023 | — |
| CORRESP | Letter to the SEC | May 8, 2023 | — |
| UPLOAD | Letter from the SEC | May 5, 2023 | — |
| EFFECT | Filing | Aug 2, 2022 | — |
| EFFECT | Filing | Jun 6, 2022 | — |
| CORRESP | Letter to the SEC | Jun 2, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 1, 2022 | — |
| UPLOAD | Letter from the SEC | Feb 1, 2022 | — |
| CORRESP | Letter to the SEC | Jan 27, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 24, 2022 | — |
| CERT | Filing | Jul 17, 2020 | — |
| EFFECT | Filing | Jul 16, 2020 | — |
| EFFECT | Filing | Jul 16, 2020 | — |
| CORRESP | Letter to the SEC | Jul 14, 2020 | — |
| CORRESP | Letter to the SEC | Jul 14, 2020 | — |
| 8-A12B | Filing | Jul 13, 2020 | — |
| CORRESP | Letter to the SEC | Jul 6, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 1, 2020 | — |
| CORRESP | Letter to the SEC | Jun 24, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 11, 2020 | — |
| DRS | Filing | May 15, 2020 | — |
Showing 45 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- RNLXY (OTC), RENXF (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- United Kingdom
- Headquarters
- London
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1811115
- Former names
- Renalytix AI plc (until Jun 25, 2021)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.